Temper Buzz About the First Oral GLP-1 Agonist, Rybelsus

Rybelsus (reh-BEL-sus, semaglutide) will be the first ORAL GLP-1 agonist for type 2 diabetes...it's a tablet version of injectable Ozempic.

Glucagon-like peptide-1 (GLP-1) is inactivated in the stomach.

That's why other GLP-1 agonists...Bydureon (exenatide), Trulicity (dulaglutide), Victoza (liraglutide), etc...are injected.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote